Viewing Study NCT05241132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2026-02-03 @ 5:41 AM
Study NCT ID: NCT05241132
Status: UNKNOWN
Last Update Posted: 2022-02-15
First Post: 2022-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Sponsor: Wei Xu
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer of Unknown Primary View
None Bone Cancer Metastatic View
None Tislelizumab View
None Gene Mutation-Related Cancer View
None Immune Evasion, Tumor View
None Chemotherapy Effect View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bone metastases from cancer of unknown primary View
None Cancer of unknown primary View
None Tislelizumab View
None Chemotherapy Effect View
None Immunotherapy View
None Gene expression spectrum View